Evidence map›Paper›PMID 33660531›Full record

ArticleJournal of diabetes science and technology2022

Feasibility of Real-Time Continuous Glucose Monitoring Telemetry System in an Inpatient Diabetes Unit: A Pilot Study.

Clémentine Dillmann, Lamia Amoura, Fatéma Fall Mostaine, Adrien Coste, Leila Bounyar, Laurence Kessler

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Journal of diabetes science and technology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07194642 (Feasibility and Performance of Continuous Glucose Monitoring to Guide Computerized Insulin Infusion Therapy in Non-ICU Patients Receiving Corticosteroid Therapy and Specialized Nutrition), which is not on this map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07194642 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Feasibility and Performance of Continuous Glucose Monitoring to Guide Computerized Insulin Infusion Therapy in Non-ICU Patients Receiving Corticosteroid Therapy and Specialized Nutrition

TypeinterventionalSponsorUniversity of NebraskaRan2026 to 2026Enrolled80ConditionsDiabetesArmsDexcom G7 CGM
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. [Hospital diabetes management (Update 2023)].Wiener klinische Wochenschrift · 2023
    Article
  15. Continuous glucose monitoring in the hospital: an update in the era of COVID-19.Current opinion in endocrinology, diabetes, and obesity · 2022
    Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Clémentine DillmannDepartment of Diabetology, University Hospital of Strasbourg, France.ORCID 0000-0002-9835-8339
Lamia AmouraDepartment of Diabetology, University Hospital of Strasbourg, France.
Fatéma Fall MostaineDepartment of Diabetology, University Hospital of Strasbourg, France.
Adrien CosteDepartment of Diabetology, University Hospital of Strasbourg, France.
Leila BounyarDepartment of Diabetology, University Hospital of Strasbourg, France.
Laurence KesslerDepartment of Diabetology, University Hospital of Strasbourg, France.
Hôpitaux Universitaires de Strasbourg · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHospitalization of persons with diabetes in an inpatient diabetes unit is challenging, notably for patients having different profiles. We aimed to evaluate the feasibility and the benefit of a continuous glucose monitoring (CGM) telemetry system to control glucose excursions in hospitalized patients with diabetes, according to their diabetes type and the reasons for their hospitalization.

methodA prospective pilot study was conducted in 53 insulin-requiring diabetes patients hospitalized in the general ward. Glucose was monitored using Guardian Connect (GC, Medtronic) to adopt insulin therapy. The time in range (TIR, target 70-180 mg/dL), the time below range (TBR), and the time above range (TAR) were recorded by GC between the start of hospitalization (SH) and end of hospitalization (EH), and analyzed according to the diabetes type (type 1 diabetes

resultsIn patients with type 2 diabetes and those hospitalized for acute complications, TIR significantly increased between the SH and EH, from 75.7% (95%CI 48.5-84.6) to 82.2% (95%CI 63.2-91.8)

conclusionsCGM telemetry system use is feasible and well accepted in patients hospitalized in diabetes care unit and could be useful to improve therapeutic education and metabolic control, especially for specific homogenous populations with diabetes.

Indexed as

Blood Glucose Self-MonitoringDiabetes Mellitus, Type 2Blood GlucoseFeasibility StudiesHumansInpatientsInsulinPilot ProjectsProspective StudiesTelemetryBlood GlucoseInsulincontinuous glucose monitoringhospitalizationtherapeutic educationtime in range

Identifiers

PMID33660531
PMCPMC9264424
OpenAlexW3133968840

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.